4.5 Article

The headache registry of the German Migraine and Headache Society (DMKG): baseline data of the first 1,351 patients

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Anesthesiology

Characteristic values and test statistical goodness of the Veterans RAND 12-Item Health Survey (VR-12) in patients with chronic pain An evaluation based on the KEDOQ pain dataset

M. Hueppe et al.

Summary: The study evaluated the use of the VR-12 in the German Pain Questionnaire among patients with chronic pain, with results indicating that the VR-12 is an appropriate substitute for the SF-12, effectively assessing patients' health-related quality of life.

SCHMERZ (2022)

Article Clinical Neurology

Impact of abuse on migraine-related sensory hypersensitivity symptoms: Results from the American Registry for Migraine Research

Meesha Trivedi et al.

Summary: This study found an association between a history of abuse and migraine-related sensory hypersensitivity symptoms. Patients with abuse history reported more frequent headaches and higher levels of emotional symptoms, such as anxiety and depression, as well as various sensory hypersensitivity symptoms. Abuse was directly linked to sensory hypersensitivity and mediated by anxiety and depression, indicating the need for further research on mechanistic connections between abuse and migraine symptoms.

HEADACHE (2021)

Article Clinical Neurology

The American Headache Society Consensus Statement: Update on integrating new migraine treatments into clinical practice

Jessica Ailani et al.

Summary: This update aims to incorporate recent research findings, expert consensus, and patient perspectives into updated guidance on the use of new acute and preventive treatments for migraine in adults. It provides practical recommendations based on expanded evidence base and emerging expert consensus, in the absence of a formal guideline.

HEADACHE (2021)

Article Clinical Neurology

MAB-MIG: registry of the spanish neurological society of erenumab for migraine prevention

Robert Belvis et al.

Summary: In a personalized managed access program in Spain, erenumab demonstrated good effectiveness and excellent tolerability in migraine prevention for refractory patients, with most patients suffering from chronic migraine and medication overuse headache. Patients who had lower HIT-6 scores, more prior preventive treatment failures, no medication overuse headache, and simultaneous BoNT/A treatment were more likely to have a good response to erenumab.

JOURNAL OF HEADACHE AND PAIN (2021)

Article Clinical Neurology

Use of outpatient medical care by headache patients in Germany: a population-based cross-sectional study

Britta Mueller et al.

JOURNAL OF HEADACHE AND PAIN (2020)

Article Clinical Neurology

Poor medical care for people with migraine in Europe - evidence from the Eurolight study

Zaza Katsarava et al.

JOURNAL OF HEADACHE AND PAIN (2018)

Article Primary Health Care

Prophylactic treatment of migraine by GPs: a qualitative study

Frans Dekker et al.

BRITISH JOURNAL OF GENERAL PRACTICE (2012)